Could a single friendly gut bacterium prevent recurrent c. diff?

NCT ID NCT06306014

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 5 times

Summary

This study tests EXL01, a single strain of a beneficial gut bacterium (Faecalibacterium prausnitzii), to see if it can prevent repeat Clostridioides difficile infections in people at high risk. About 56 adults who have had at least two C. diff episodes will take EXL01 or a placebo by mouth. The goal is to see if this treatment is safe and reduces the chance of another infection at 8 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHM La Timone Service de Maladies infectieuses

    RECRUITING

    Marseille, France

  • CH Annecy Genevois Service de Maladies infectieuses

    NOT_YET_RECRUITING

    Annecy, France

  • CHU Grenoble Service Maladies infectieuses et tropicales

    RECRUITING

    Grenoble, France

  • CHU Lille Unité des Maladies Infectieuses et tropicales

    NOT_YET_RECRUITING

    Lille, France

  • Service d'Hépato-gastroentérologie Hôpital de la Croix Rousse

    RECRUITING

    Lyon, 69004, France

  • Service d'hépato-gastroentérologie - CHU Estaing

    RECRUITING

    Clermont-Ferrand, 63003, France

  • Service d'hépato-gastroentérologie - Hôpital Saint Antoine (APHP)

    RECRUITING

    Paris, 75012, France

  • Service d'infectiologie - Hôpital Nord / CHU Saint Etienne

    RECRUITING

    Saint-Etienne, 42100, France

  • Service de Maladies Infectieuses - CH de Valence

    RECRUITING

    Valence, 26000, France

  • Service de médecine interne - Pôle des maladies de l'appareil digestif - CHU de Toulouse

    RECRUITING

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.